Stockreport

Novo weight loss therapy cuts mortality risk in kidney disease [Seeking Alpha]

Outset Medical, Inc.  (OM) 
PDF the risk of death by 20% in a study for patients with type 2 diabetes and chronic kidney disease. In October, the Danish drugmaker announced an early end to the trial [Read more]